Related Experiment Video
Updated: Aug 3, 2026

07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Benzodiazepine modulation of opiate reward
1Department of Psychology, University of California, Santa Barbara 93106, USA.
Experimental and Clinical Psychopharmacology
|August 24, 2001
Summary
Benzodiazepines (BDZs) may enhance the euphoric effects of opiates. This study found that alprazolam pretreatment increased heroin
Area of Science:
- Neuroscience
- Psychopharmacology
- Addiction Research
Background:
- Opiate addiction is a major public health concern.
- Benzodiazepines (BDZs) are frequently co-administered with opiates by users.
- BDZs are hypothesized to enhance the reinforcing effects of opiates.
Purpose of the Study:
- To investigate if benzodiazepine pretreatment augments the reinforcing properties of heroin.
- To test the hypothesis that BDZs enhance the affective response to opiates.
Main Methods:
- Sprague-Dawley rats were used in a conditioned place preference paradigm.
- Rats received intraperitoneal alprazolam pretreatment before intravenous heroin administration.
- Heroin dose-response curves were analyzed in the presence and absence of alprazolam.
Main Results:
- Alprazolam pretreatment resulted in a leftward shift of the heroin dose-response curve.
- This indicates that lower doses of heroin were needed to establish conditioned place preference with alprazolam.
- The findings suggest an augmentation of heroin's effects by alprazolam.
Conclusions:
- Benzodiazepines, specifically alprazolam, can enhance the affective and reinforcing properties of heroin in rats.
- This supports the hypothesis that co-administration of BDZs with opiates intensifies their effects.
- The study provides animal model evidence for the observed patterns in human opiate users.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

